tDCS + Speech Therapy for Aphasia
Trial Summary
What is the purpose of this trial?
The purpose of this study is to assess changes in language abilities of participants with chronic, post-stroke aphasia following an 8-week therapy period combined with brain stimulation. The investigators use a stimulation method called transcranial direct current stimulation (tDCS). The investigators cover two electrodes in damp sponges, place them on the scalp, and pass a weak electrical current between them. Some of this current passes through the brain and can change brain activity. One electrode is placed over language areas a bit above and in front of the left ear. The other is placed on the forehead above the right eye. Stimulation is provided twice a week for 8 weeks during aphasia therapy. The investigators believe that this stimulation may increase the effectiveness of therapy.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have a history of seizures or have changed seizure medication in the past 12 months, you may be excluded from participating.
What data supports the effectiveness of the treatment tDCS + Speech Therapy for Aphasia?
Research suggests that combining transcranial direct current stimulation (tDCS) with speech therapy can improve language skills in people with aphasia after a stroke, especially when applied early in rehabilitation. This combination seems to enhance brain activity and language performance more effectively than speech therapy alone.12345
Is tDCS combined with speech therapy safe for humans?
How does the tDCS + Speech Therapy treatment for aphasia differ from other treatments?
The tDCS + Speech Therapy treatment is unique because it combines traditional speech therapy with transcranial direct current stimulation (tDCS), a non-invasive method that uses a low-intensity electrical current to stimulate the brain and potentially enhance language recovery in stroke patients with aphasia.68101112
Research Team
E. Susan Duncan, PhD, CCC-SLP
Principal Investigator
City University of New York
Eligibility Criteria
This trial is for right-handed, English-speaking adults with a high school education who had a single-event left hemisphere stroke over 6 months ago and have chronic aphasia. They must not be receiving other speech therapies during the study or have any conditions that would interfere with MRI scans, such as metal implants or pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Treatment Assessment
Participants complete behavioral assessments and brain scans before therapy
Treatment
Participants receive tDCS and aphasia therapy for 8 weeks
Post-Treatment Assessment
Behavioral assessments and brain scans are conducted immediately after therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Anodal transcranial direct current stimulation
- Sham transcranial direct current stimulation
- Speech-Language Therapy (SLT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Louisiana State University and A&M College
Lead Sponsor
City University of New York
Lead Sponsor